Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

NOVABAY PHARMACEUTICALS

(NBY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

NovaBay Pharmaceuticals to Present at the Ladenburg Thalmann 2022 Healthcare Conference

09/23/2022 | 06:51am EST

 

NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces that management will present at the Ladenburg Thalmann 2022 Healthcare Conference on Thursday, September 29 at 9:00 a.m. Eastern time (6:00 a.m. Pacific time). The conference is being held at the Sofitel Hotel New York. A webcast of the presentation will be available on the Events page of the company website.

About NovaBay Pharmaceuticals, Inc:

NovaBay Pharmaceuticals, Inc. is a pharmaceutical company that develops and sells scientifically created and clinically proven consumer products for the eyecare and skincare markets. Avenova® is the most prescribed antimicrobial lid and lash spray and DERMAdoctor® is a premium skincare brand offering more than 30 dermatologist-developed skincare products sold through traditional domestic retailers, digital beauty channels and international distributors.

Socialize and Stay Informed on NovaBays Progress
Like us on Facebook
Follow us on Twitter
Connect with NovaBay on LinkedIn
Visit NovaBay’s Website

Avenova Purchasing Information
For NovaBay Avenova purchasing information:
Please call 800-890-0329 or email sales@avenova.com
Avenova.com

DERMAdoctor Purchasing Information
For DERMAdoctor purchasing information:
Please call 877-337-6237 or email service@dermadoctor.com
DERMAdoctor.com


ę Business Wire 2022
All news about NOVABAY PHARMACEUTICALS
11/30NovaBay Pharmaceuticals Announces the Launch of DERMAdoctor's TikTok Store in China and..
AQ
11/29NovaBay Pharmaceuticals Announces the Launch of DERMAdoctor's TikTok Store in China and..
BU
11/18Novabay Pharmaceuticals, Inc. : Entry into a Material Definitive Agreement, Amendments to ..
AQ
11/18NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin Returns to the QVC Netwo..
AQ
11/17NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin Returns to the QVC« Netw..
BU
11/16NOVABAY PHARMACEUTICALS : REVERSE SPLIT: 1 of 35
FA
11/14Novabay Pharmaceuticals, Inc. : Submission of Matters to a Vote of Security Holders, Other..
AQ
11/14NOVABAY PHARMACEUTICALS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDIT..
AQ
11/14Transcript : NovaBay Pharmaceuticals, Inc., Q3 2022 Earnings Call, Nov 14, 20..
CI
11/14NovaBay Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine M..
CI
More news
Analyst Recommendations on NOVABAY PHARMACEUTICALS
More recommendations
Financials (USD)
Sales 2022 14,2 M - -
Net income 2022 -5,97 M - -
Net Debt 2022 - - -
P/E ratio 2022 -0,51x
Yield 2022 -
Capitalization 3,83 M 3,83 M -
Capi. / Sales 2022 0,27x
Capi. / Sales 2023 0,18x
Nbr of Employees 30
Free-Float -
Chart NOVABAY PHARMACEUTICALS
Duration : Period :
NOVABAY PHARMACEUTICALS Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NOVABAY PHARMACEUTICALS
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 2,07 $
Average target price 15,00 $
Spread / Average Target 626%
EPS Revisions
Managers and Directors
Justin M. Hall President, CEO, Director & General Counsel
Andrew Jones Chief Financial Officer & Treasurer
Paul E. Freiman Chairman
Yen You Zheng Independent Director
Swan Sit Independent Director